U Y Fincorp Fund Raise of ₹187.2 Cr

U Y Fincorp Q2 FY27 Results: Net Profit ₹22.1 Cr, Up 172.8% YoY

U Y Fincorp Ltd reported revenue from operations of ₹66.5 Cr (+144.5% YoY) and net profit of ₹22.1 Cr (+172.8% YoY) for Q2 FY27.

Key figure

Net profit ₹22.1 Cr · +172.8% YoY

U Y Fincorp Board Meeting Date

U.Y. Fincorp Limited has given prior intimation of a board meeting on 2 November 2026 to consider unaudited results for the quarter and half year ended 30 September 2026 and a proposed fund raise. No amount is stated, and the trading window stays closed until 48 hours after results.

U Y Fincorp Business Update

U.Y. Fincorp has appointed M/s Merlin Capital Advisors as its Investor Relations and Public Relations agency to provide advisory services effective October 17, 2026.

U Y Fincorp Other Announcement

U. Y. Fincorp Ltd submitted its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.

U Y Fincorp Management Change

U. Y. Fincorp Limited announced the re-appointment of an Executive Director, the retirement by rotation of another Executive Director, and the appointment of a new Statutory Auditor.

U Y Fincorp Annual General Meeting

U.Y. Fincorp Limited held its 33rd Annual General Meeting on September 30, 2026. Shareholders approved audited financial statements, director re-appointments, and material related party transactions.

Rajkot Investment Trust Fund Raise of ₹48 Cr

Rajkot Investment Trust's board approved a Rs 48 Crore rights issue of equity shares. Pricing and record date will be set later by a committee.

Value

₹48.00 Cr

Rite Zone Chemcon India Fund Raise of ₹6.58 Cr

Rite Zone Chemcon India announced a preferential issue of 27,69,730 equity shares to 11 investors at Rs.24 each, raising about Rs.6.58 Crore. The approval awaits a shareholder vote on 23 November 2026.

Value

₹6.58 Cr

Sudarshan Pharma Industries Fund Raise of ₹72 Cr

Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.

Value

₹72.00 Cr

Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr

Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.

Value

₹68.20 Cr

Kanel Industries Fund Raise of ₹16.99 Cr

Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.

Value

₹16.99 Cr

Execution

Rights issue opens 23 November 2026 and closes 30 November 2026

Sudarshan Pharma Industries Fund Raise

Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.